A, B., MO, N., A, T., J, H., J, S., & JS, L. (2023). Spectrum of Dermatologic Adverse Events Associated With Amivantamab Use. JAMA dermatology, 159(1), 109. https://doi.org/10.1001/jamadermatol.2022.4466
Chicago Style (17th ed.) CitationA, Belzer, Nguyen MO, Talsania A, Haldas J, Smith J, and Leventhal JS. "Spectrum of Dermatologic Adverse Events Associated With Amivantamab Use." JAMA Dermatology 159, no. 1 (2023): 109. https://doi.org/10.1001/jamadermatol.2022.4466.
MLA (9th ed.) CitationA, Belzer, et al. "Spectrum of Dermatologic Adverse Events Associated With Amivantamab Use." JAMA Dermatology, vol. 159, no. 1, 2023, p. 109, https://doi.org/10.1001/jamadermatol.2022.4466.
Warning: These citations may not always be 100% accurate.